| Literature DB >> 15079855 |
Abstract
A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed. Copyright 2004 John Wiley & Sons, Ltd.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15079855 DOI： 10.1002/hup.578
Source DB: PubMed Journal: Hum Psychopharmacol ISSN： 0885-6222 Impact factor: 1.672